Literature DB >> 19016003

Calcitonin induces expression of the inducible cAMP early repressor in osteoclasts.

Maobin Yang1, Barbara E Kream.   

Abstract

The cAMP response element modulator gene (Crem) encodes a variety of transcriptional regulators including the inducible cAMP early repressor, ICER. We previously showed that Crem knockout mice, which are deficient in CREM and ICER factors, display slightly increased long bone mass and decreased osteoclast number. These data are consistent with the notion that Crem regulates bone mass in part through an effect on osteoclast formation and/or function. Since ICER is strongly induced by cAMP, we asked whether the calcium-regulating hormone calcitonin, which stimulates cAMP production and inhibits osteoclastic bone resorption, could induce ICER in osteoclasts. The monocytic cell line RAW264.7 was treated with receptor activator of NF-kappaB ligand (RANKL) to induce osteoclast formation. Calcitonin caused a time- and dose-dependent induction of ICER mRNA and an increase in ICER protein abundance in RANKL-treated RAW264.7 cells. Calcitonin also induced ICER mRNA and protein in osteoclasts derived from primary mouse bone marrow cell cultures. Calcitonin-treated osteoclasts showed immunoreactivity with an anti-CREM antibody. Calcitonin decreased the activity of wild-type and Crem knockout osteoclasts in vitro, and this inhibitory effect was greater in Crem knockout osteoclasts. Furthermore, calcitonin decreased calcitonin receptor mRNA expression in wildtype osteoclasts, but not in Crem knockout osteoclasts. These data suggest that calcitonin induction of ICER in osteoclasts might regulate osteoclast activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19016003      PMCID: PMC2858383          DOI: 10.1007/s12020-008-9092-8

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  57 in total

1.  CREM deficiency in mice alters the response of bone to intermittent parathyroid hormone treatment.

Authors:  Fei Liu; Sun-Kyeong Lee; Douglas J Adams; Gloria A Gronowicz; Barbara E Kream
Journal:  Bone       Date:  2007-02-01       Impact factor: 4.398

2.  Contribution of nuclear factor of activated T cells c1 to the transcriptional control of immunoreceptor osteoclast-associated receptor but not triggering receptor expressed by myeloid cells-2 during osteoclastogenesis.

Authors:  Yoonji Kim; Kojiro Sato; Masataka Asagiri; Ikuo Morita; Kunimichi Soma; Hiroshi Takayanagi
Journal:  J Biol Chem       Date:  2005-07-26       Impact factor: 5.157

3.  Altered emotional and locomotor responses in mice deficient in the transcription factor CREM.

Authors:  R Maldonado; C Smadja; C Mazzucchelli; P Sassone-Corsi; C Mazucchelli
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

4.  Control of cyclic adenosine 3',5'-monophosphate production in osteoclasts: calcitonin-induced persistent activation and homologous desensitization of adenylate cyclase.

Authors:  G C Nicholson; J M Moseley; A J Yates; T J Martin
Journal:  Endocrinology       Date:  1987-05       Impact factor: 4.736

5.  Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation.

Authors:  S K Lee; J A Lorenzo
Journal:  Endocrinology       Date:  1999-08       Impact factor: 4.736

6.  Identification of novel cAMP responsive element modulator (CREM) isoforms expressed by osteoblasts.

Authors:  F Liu; Y-F Huang; B E Kream
Journal:  Calcif Tissue Int       Date:  2005-07-28       Impact factor: 4.333

7.  Regulation of osteoclast differentiation and function by the CaMK-CREB pathway.

Authors:  Kojiro Sato; Ayako Suematsu; Tomoki Nakashima; Sayaka Takemoto-Kimura; Kazuhiro Aoki; Yasuyuki Morishita; Hiroshi Asahara; Keiichi Ohya; Akira Yamaguchi; Toshiyuki Takai; Tatsuhiko Kodama; Talal A Chatila; Haruhiko Bito; Hiroshi Takayanagi
Journal:  Nat Med       Date:  2006-11-26       Impact factor: 53.440

Review 8.  Calcitonin.

Authors:  P M Sexton; D M Findlay; T J Martin
Journal:  Curr Med Chem       Date:  1999-11       Impact factor: 4.530

9.  Negative regulation of TLR responses by the neuropeptide CGRP is mediated by the transcriptional repressor ICER.

Authors:  Marit D Harzenetter; Alexander R Novotny; Petra Gais; Carlos A Molina; Felicitas Altmayr; Bernhard Holzmann
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

10.  A novel promoter regulates calcitonin receptor gene expression in human osteoclasts.

Authors:  Zhenxin Shen; Tania N Crotti; Merrilee R Flannery; Kenichiro Matsuzaki; Steven R Goldring; Kevin P McHugh
Journal:  Biochim Biophys Acta       Date:  2007-09-12
View more
  7 in total

1.  Col3.6-HSD2 transgenic mice: a glucocorticoid loss-of-function model spanning early and late osteoblast differentiation.

Authors:  Maobin Yang; Lorin B Trettel; Douglas J Adams; John R Harrison; Ernesto Canalis; Barbara E Kream
Journal:  Bone       Date:  2010-06-09       Impact factor: 4.398

2.  Osteoclasts are not activated in middle ear cholesteatoma.

Authors:  Hiroki Koizumi; Hideaki Suzuki; Shoji Ikezaki; Toyoaki Ohbuchi; Koichi Hashida; Akinori Sakai
Journal:  J Bone Miner Metab       Date:  2015-03-22       Impact factor: 2.626

3.  Characterization of stem and progenitor cells in the dental pulp of erupted and unerupted murine molars.

Authors:  Anamaria Balic; H Leonardo Aguila; Melissa J Caimano; Victor P Francone; Mina Mina
Journal:  Bone       Date:  2010-02-26       Impact factor: 4.398

4.  Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts.

Authors:  Johannes Keller; Philip Catala-Lehnen; Antje K Huebner; Anke Jeschke; Timo Heckt; Anja Lueth; Matthias Krause; Till Koehne; Joachim Albers; Jochen Schulze; Sarah Schilling; Michael Haberland; Hannah Denninger; Mona Neven; Irm Hermans-Borgmeyer; Thomas Streichert; Stefan Breer; Florian Barvencik; Bodo Levkau; Birgit Rathkolb; Eckhard Wolf; Julia Calzada-Wack; Frauke Neff; Valerie Gailus-Durner; Helmut Fuchs; Martin Hrabĕ de Angelis; Susanne Klutmann; Elena Tsourdi; Lorenz C Hofbauer; Burkhard Kleuser; Jerold Chun; Thorsten Schinke; Michael Amling
Journal:  Nat Commun       Date:  2014-10-21       Impact factor: 14.919

5.  Undercarboxylated osteocalcin inhibits the early differentiation of osteoclast mediated by Gprc6a.

Authors:  Hailong Wang; Jinqiao Li; Zihan Xu; Feng Wu; Hongyu Zhang; Chao Yang; Jian Chen; Bai Ding; Xiukun Sui; Zhifeng Guo; Yinghui Li; Zhongquan Dai
Journal:  PeerJ       Date:  2021-03-02       Impact factor: 2.984

6.  Parental Origin of Gsα Inactivation Differentially Affects Bone Remodeling in a Mouse Model of Albright Hereditary Osteodystrophy.

Authors:  Patrick McMullan; Peter Maye; Qingfen Yang; David W Rowe; Emily L Germain-Lee
Journal:  JBMR Plus       Date:  2021-11-16

7.  Impact of dietary aromatic amino acids on osteoclastic activity.

Authors:  Mona El Refaey; Qing Zhong; Ke-Hong Ding; Xing-Ming Shi; Jianrui Xu; Wendy B Bollag; William D Hill; Norman Chutkan; Richard Robbins; Hugh Nadeau; Maribeth Johnson; Mark W Hamrick; Carlos M Isales
Journal:  Calcif Tissue Int       Date:  2014-07-08       Impact factor: 4.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.